Endotoxin, reticuloendothelial function, and liver injury

HepatologyVolume 1, Issue 5 p. 458-465 Special ArticleFree Access Endotoxin, reticuloendothelial function, and liver injury James P. Nolan M.D., Corresponding Author James P. Nolan M.D. Professor and Chairman Department of Medicine, State University of New York at Buffalo, Buffalo, New York 14215Department of Medicine, State University of New York at Buffalo, 462 Grider Street, Buffalo, New York 14215===Search for more papers by this author James P. Nolan M.D., Corresponding Author James P. Nolan M.D. Professor and Chairman Department of Medicine, State University of New York at Buffalo, Buffalo, New York 14215Department of Medicine, State University of New York at Buffalo, 462 Grider Street, Buffalo, New York 14215===Search for more papers by this author First published: September/October 1981 https://doi.org/10.1002/hep.1840010516Citations: 278AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Nolan JP. The role of endotoxin in liver injury. Gastroenterology 1975; 69: 1346–1356. 2 Leach BE, Forbes JC. Sulfonamide drugs as protective agents against carbon tetrachloride poisoning. Proc Soc Exp Biol Med 1941; 48: 361–363. 3 Luckey TD, Reyniers JA, Gyorgy P, et al. Germ free animals and liver necrosis. Ann NY Acad Sci 1954; 57: 925–932. 4 Rutenburg AM, Sonnenblick E, Koven I, et al. The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 1957; 106: 1–13. 5 Salmon WD, Newborne PM. Effect of antibiotics, sulfonamides and a nitrofuran on development of hepatic cirrhosis in choline-deficient rats. J Nutr 1962; 76: 483–486. 6 Formal SB, Noyes HE, Schneider H. Experimental shigella infections. III. Sensitivity of normal, starved and carbon tetrachloride treated guinea pigs to endotoxin. Proc Soc Exp Biol Med 1960; 103: 415–418. 7 Farrar WE, Edison M, Kant TH. Susceptibility of rabbits to pyrogenic and lethal effects of endotoxin after acute liver injury. Proc Soc Exp Biol Med 1968; 128: 711–715. 8 Nolan JP, Ali MV. Endotoxin and the liver. I. Toxicity in rats with choline deficient fatty livers. Proc Soc Exp Biol Med 1968; 129: 29–31. 9 Wisse E, Noordende JM, Meulen J, et al. The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tiss Res 1976; 173: 423–428. 10 Wisse, E. Ultrastructure and function of Kupffer cells and other sinusoidal cells in the liver. In: E Wisse, DL Knook, eds. Kupffer cells and other sinusoidal cells. Amsterdam: Elsevier/North Holland Biomedical Press, 1977: 33–60. 11 Gale RP, Sparkes RS, Golde DW. Bone marrow origin of Kupffer cells in humans. Science 1978; 201: 937–938. 12 Heine WD. Proliferation kinetics of Kupffer cells. In: H Liehr, M. Grun eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1980: 27–44. 13 Wanson JC, Drochmans P, Mosselmans R, et al. Symbiotic culture of adult hepatocytes and sinus-lining cells. In: E Wisse, DL Knook, eds. Kupffer cells and other liver sinusoidal cells. Amsterdam: Elsevier/North Holland Biomedical Press, 1977: 141–150. 14 Saba TM. Physiologic role for cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic L2-SB-glycoprotein. Ann NY Acad Sci 1978; 312: 43–55. 15 Wisse E, DeZanger RB. On the morphology and other aspects of Kupffer cell function: observations and speculations concerning pinocytosis and phagocytosis. In: H Liehr, M Grun, eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1980: 3–9. 16 Andersen JM, Turley SD, Dietschy JM. Low and high density lipoproteins and chylomicrons as regulators of rate of cholesterol synthesis in rat liver in vivo. Proc Natl Acad Sci 1979; 76: 165–169. 17 Wooles WR, DiLuzio NR. The phagocytic and proliferative response of the reticuloendothelial system following glucan administration. J Reticuloendothel Soc 1964; 1: 160–169. 18 Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93: 527–616. 19 Fine DP. Activation of the classic and alternate complement pathways by endotoxin. J Immunol 1974; 112: 763–769. 20 Rudbach JA. Molecular immunogenicity of bacterial lipopolysaccharide antigens. J Immunol 1971; 106: 993–1001. 21 Nolan JP, O'Connell CJ. Vascular response in the isolated rat liver. I. Endotoxin, direct effect. J Exp Med 1965; 122: 1063–1073. 22 Utili R, Abernathy CO, Zimmerman HJ. Cholestatic effects of E. coli endotoxin on the isolated perfused rat liver. Gastroenterology 1976; 70: 248–253. 23 Watson J, Largen M, McAdam KPWJ. Genetic control of endotoxic responses in mice. J Exp Med 1978; 147: 39–49. 24 Golde LM, Scher I, Osborne B, et al. Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice. J Immunol 1976; 116: 454–461. 25 Mergenhagen SE (moderator). Endogenous mediators in host responses to bacterial endotoxin. In: D Schlessinger, ed. Microbiology. Washington, D. C.: American Society for Microbiology, 1980: 33–171. 26 Weissmann G. Thomas L. Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med 1962; 116: 433–450. 27 Bissell DM, Hammaker LM. Cytochrome P-450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys 1976; 176: 91–102. 28 Mela L. Miller LD, Bacalozo LV, et al. Role of intracellular variations of lysosomal enzyme activity and oxygen tension in mitochondrial impairment in endotoxemia and hemorrhage. Ann Surg 1973; 178: 727–73. 29 Del'alma RG, Harano Y, Robinson AV, et al. Structure and function of hepatic mitochondria in hemorrhage and endotoxemia. Surg Forum 1970; 21: 3–6. 30 Utili R, Abernathy CO, Zimmerman HJ. Studies on the effects of E. coli endotoxin on canalicular bile formation in the isolated perfused rat liver. J Lab Clin Med 1977; 89: 471–482. 31 Utili R, Abernathy CO, Zimmerman HJ, et al. Hepatic excretory function in the endotoxin tolerant rat. Proc Soc Exp Biol Med 1979; 161: 554–557. 32 Levin J. Endotoxin and endotoxemia. N Engl J Med 1973; 288: 1297–1298. 33 Selye H, Tuchweber B, Bertok L. Effect of lead acetate on the susceptibility of rats to bacterial endotoxins. J Bacteriol 1969; 91: 884–890. 34 Munoz JJ, Bergman RK, Robbins KE. Comparison of the histamine hypersensitivity and the limulus amoebocyte lysate test for endotoxin activity. Infect and Immun 1978; 22: 292–294. 35 Leibowitz AI, Vladutiu AO, Nolan JP. Immunoradiometric Assay of endotoxin in the serum. Clin Chem 1979; 25: 68–70. 36 Ali MV, Nolan JP. Alcohol induced depression of reticuloendothelial function in the rat. J Lab Clin Med 1967; 70: 295–301. 37 Ali MV, Nolan JP. Serial assessment of reticuloendothelial function in experimentally induced nutritional cirrhosis. Lab Invest 1969; 21: 184–189. 38 Cooksley WGE, Powell LW, Halliday JW. Reticuloendothelial phagocytic function in human liver disease and its relationship to haemolysis. Br J Haematol 1973; 25: 147–152. 39 Liu YK. Phagocytic capacity of reticuloendothelial system in alcoholies. J Reticuloendothel Soc 1979; 25: 605–613. 40 Nolan JP, Leibowitz AI, Vladutiu AL. Influence of alcohol on Kupffer cell function and possible significance in liver injury. In H Liehr, M Grun, eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1980: 125–136. 41 Nolan JP, Leibowitz A, Vladutiu AL. Influence of carbon tetrachloride on circulating endotoxin after exogenous administration of endotoxin in rats. Proc Soc Exp Biol Med 1980; 165: 453–456. 42 Broitman SA, Gottlieb LS, Zamcheck N. Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat. J Exp Med 1964; 119: 633–641. 43 Nolan JP, Ali MV. Endotoxin and the liver. II. Effect of tolerance on carbon tetrachloride induced injury. J Med 1973; 4: 28–38. 44 Lopes J, Inniss WE. Electron microscopy of effect of polymyxin B on E. coli lipopolysaccharide. J Bacteriol 1969; 100: 1128–1130. 45 Nolan JP, Leibowitz AI. Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin B–An antiendotoxin. Gastroenterology 1978; 75: 445–449. 46 Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974; 71: 78–106. 47 Grun M, Liehr H, Rasenack U. Significance of endotoxemia in experimental “galactosamine hepatitis” in the rat. Acta Hepato Gastroenterol 1976; 23: 64–81. 48 Liehr H, Grun M, Seelig H, et al. On the pathogenesis of galactosamine hepatitis. Virchows Arch B Cell Pathol 1978; 26: 331–344. 49 Rasenack J, Koch AK, Nowack J, et al. Hepatotoxicity of Dgalactosamine in the isolated perfused rat liver. Exp Mol Path 1980; 32: 264–275. 50 Gut JP, Steffan AM, Anton M, et al. Kupffer cell functions and frog virus 3 hepatitis in mice and rats. In: H Liehr, M Grun, eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1980; 211–219. 51 Triger DR, Alp MH, Wright R. Bacterial and dietary antibodies in liver disease. Lancet 1972; 1: 60–63. 52 Bjorneboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1972; 1: 58–60. 53 Jacob AI, Goldberg PK, Bloom N, et al. Endotoxin and bacteria in the portal blood. Gastroenterology 1977; 72: 1268–1270. 54 Prytz H, Hoest-Christensen J, Korner B, et al. Portal venous and systemic endotoxemia in patients without liver disease, and systemic endotoxemia in patients with cirrhosis. Scand J Gastroent 1976; 11: 857–863. 55 Fulenwider JT, Sibley C, Stein SF, et al. Endotoxemia of cirrhosis: an observation not substantiated. Gastroenterology 1980; 78: 1001–1004. 56 Nolan JP, Hare DK, McDevitt JJ, et al. In vitro studies of intestinal endotoxin absorption. Kinetics of absorption in the isolated everted gut sac. Gastroenterology 1977; 72: 434–439. 57 Epstein M, Berk DP, Hollenberg NK, et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175–185. 58 Wilkinson SP, Arroyo V, Gazzard BG, et al. Relationship of renal impairment and hemorrhagic dirthesis to endotoxemia in fulminant hepatic failure. Lancet 1974; 1: 521–524. 59 Clemente C, Bosch J, Rodes J, et al. Functional renal failure and hemorrhagic gastritis associated with endotoxemia in cirrhosis. Gut 1977; 18: 556–560. 60 Van Vliet ACM, Maas HCM, Wilson JHP. The effect of portasystemic shunting and RES function on endotoxemia in human liver disease. In: H Liehr, M Grun, eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier/North Holland Biomedical Press, 1980: 159–164. 61 Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976; 63: 774–778. 62 Tisdale WA, Klatskin G. The fever of Laennec's cirrhosis. Yale J Biol Med 1960; 33: 94–106. 63 Nolan JP, Ali MV. Endotoxemia in liver disease. Lancet 1974; 1: 999. 64 Haeseler F, Bodel P, Atkins E. Characteristics of pyrogen production by isolated rabbit Kupffer cells in vitro. J Reticuloendothelial Soc 1977; 22: 569–581. 65 Heyman A, Beeson PB. Influence of various disease states upon the febrile response to intravenous injection of typhoid bacterial pyrogen. J Lab Clin Med 1949; 34: 1400–1403. 66 Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reyes syndrome. Lancet 1975; 1: 1272–1274. 67 O'Leary JP, Maher JW, Hollenbeck JI, et al. Pathogenesis of hepatic failure after obesity bypass. Surg Forum 1974; 23: 356–359. 68 Tarao K, So K, Moroi T, et al. Detection of endotoxin in plasma and ascites of patients with cirrhosis: its clinical significance. Gastroenterology 1976; 73: 539–542. 69 Puig JG, Anton FM, Gonzalez JM, et al. Peritoneovenous shunt and bacterial endotoxin. Mayo Clin Proc 1979; 54: 133. 70 Goldberg PK, Kozinn PJ, Grosberg SJ, et al. Increased endotoxemia following the LeVeen peritoneovenous shunt. 78th Annual Meeting American Society for Microbiology (abstract). Las Vegas: May 1980: 152. 71 Nolan JP, Ali MV. Effect of cholestyramine on endotoxin toxicity and absorption. Am J Diggest Dis 1972; 17: 161–166. 72 Leibowitz AI, Stelzer F, Nolan JP. Modification of carbon tetrachloride induced hepatic injury by cimetidine. Clin Res 1978; 25: 760A. 73 Willson RA, Hoffman AF, Kuster GGR. Removal of cholephillic anions from dogs with biliary obstruction by hemoperfusion through charged and uncharged resins. Gastroenterology 1974; 66: 95–107. 74 Scevola D, Magliulo E, Trpin L, et al. Control of endotoxemia in liver disease by lactulose and paromomycin. Boll 1st Sierota Milan 1979; 58: 242–247. 75 Cardis DT, Woodruff PWH, Reinhold RB, et al. Endotoxemia in man. Lancet 1972; 1381–1385. 76 Wardle NE. Fibrinogen in liver disease. Arch Surg 1974; 109: 741–746. 77 Wilkinson SP, Moodie H, Stammatakis JD, et al. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976; 2: 1415–1418. 78 Liehr H, Grün M. Clinical aspects of Kupffer cell failure in liver disease. In: E Wisse, DL Knook, eds. Kupffer cells and other sinusoidal cells. Amsterdam: Elsevier/North Holland Press, 1977: 427–436. 79 Tarao K, Moroi T, Nagakura Y, et al. Relationship between endotoxemia and protein concentration of ascites in cirrhotic patients. Gut 1979; 20: 205–210. Citing Literature Volume1, Issue5September/October 1981Pages 458-465 ReferencesRelatedInformation